Today Asymmetrex continues its efforts to bring more attention to the long-standing need for tissue stem cell counting in regenerative medicine. In a post on RegMedNet, the company contrasts the quantitative dosing precision required for pharmaceutical drug trials to the complete vacuum of quantitative dosing for tissue stem cells in regenerative medicine trials. Asymmetrex invites regenerative medicine companies and physicians’ trials group to evaluate the company’s new AlphaSTEM technology for counting tissue stem cells. Asymmetrex predicts that adoption of the technology in 2016 would have a major impact on the quality of stem cell medicine clinical trials.
AsymmetrexAsymmetrex Leading the Dosing Elephant Out of Regenerative Medicine
The information provided by Asymmetrex (“we”, “us”, or “our”) on the Stem Cell Counting Center
Portal [https://asymmetrex.com/stem-cell-counting-center/] (the “Portal”) however accessed,
by internet browser or mobile application, is for general informational purposes only.
All information on the Portal is provided in good faith, however we make no representation or
warranty of any kind, express or implied, regarding the accuracy, adequacy, validity,
reliability, availability or completeness of any information provided to you by the Portal.
In specific, the Portal cannot and does not contain medical or health advice, or treatment
recommendations. The information is provided for general informational and educational purposes
only and is not a substitute for the advice of a qualified medical professional. Accordingly,
before taking any actions based upon information from the Portal, such as formulating dosage
levels and/or treatment plans, we encourage you to consult with a qualified medical professional
and/or specialist. UNDER NO CIRCUMSTANCE SHALL WE HAVE ANY LIABILITY TO YOU FOR ANY LOSS OR DAMAGE
OF ANY KIND INCURRED AS A RESULT OF THE USE OF THE PORTAL, OR RELAINCE ON ANY INFORMATION PROVIDED
BY THE PORTAL. YOU AGREE AND ARE AWARE YOUR USE OR RELIANCE OF ANY PORTAL INFORMATION IS SOLELY AT
YOUR OWN RISK.
Leave a Reply